0 citations
Irinotecan and colorectal cancer: the role of p53, VEGF-C and α-B-crystallin expression
International Journal of Colorectal Disease2009Vol. 25(7), pp. 907–907
Citations Over Time
Related Papers
- → Regorafenib: A Review in Metastatic Colorectal Cancer(2018)88 cited
- → Is regorafenib providing clinically meaningful benefits to pretreated patients with metastatic colorectal cancer?(2016)12 cited
- → Regorafenib Improves OS in Asian Patients with mCRC after Previous Failure with Standard Therapy(2014)
- → Treatment of Refractory Colorectal Cancer: Regorafenib vs. TAS-102(2017)
- → Sequenced treatment after regorafenib and survival in metastatic colorectal cancer: a qualitative clinical review(2022)